StockData

Universe Pharmaceuticals INC (UPC) stock

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.52−0.04 (-2.48%)

Close on Nov 18, 2026Market cap $857.01KP/E –Yield –

Universe Pharmaceuticals r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $671.76M, down 77.8% from the year before. The highest annual figure on record is $4.86B in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Sep 30, 2025$671.76M-77.8%
FY2024Sep 30, 2024$3.03B-37.6%
FY2023Sep 30, 2023$4.86B+63457.2%
FY2022Sep 30, 2022$7.64M+39.9%
FY2021Sep 30, 2021$5.47M+837.3%
FY2020Sep 30, 2020$583.13K-5.7%
FY2019Sep 30, 2019$618.44K–

More Universe Pharmaceuticals figures

See a number that looks wrong?